Cancer Research Meeting Calendar  Genetics and Biology of Brain Cancer
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online

[Cancer Research 56, 772-778, February 15, 1996]
© 1996 American Association for Cancer Research

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Chung, F.-L.
Right arrow Articles by Rivenson, A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Chung, F.-L.
Right arrow Articles by Rivenson, A.

Chemopreventive Efficacy of Arylalkyl Isothiocyanates and N-Acetylcysteine for Lung Tumorigenesis in Fischer Rats1

Fung-Lung Chung2, Gary Kelloff, Vernon Steele, Brian Pittman, Edith Zang, Ding Jiao, Jeffrey Rigotty, Chang-In Choi and Abraham Rivenson

Division of Carcinogenesis and Molecular Epidemiology, Naylor Dana Institute for Disease Prevention, American Health Foundation, Valhalla, New York 10595

The purpose of this study is to evaluate the efficacy of three promising sulfur-containing compounds, 6-phenylhexyl isothiocyanate (PHITC), phenethyl isothiocyanate (PEITC), and N-acetylcysteine (NAC), as chemopreventive agents in a long-term bioassay for lung tumorigenesis in F344 rats. PEITC occurs as a constituent of certain cruciferous vegetables, PHITC is a synthetic homologue, and NAC is an endogenous substance. Male F344 rats were treated with the tobacco-specific nitrosamine 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone (NNK) by s.c. injection at a dose of 1.5 mg/kg body weight three times weekly for 20 weeks. This dose regimen induced a 67% tumor incidence in the lung, a major target organ of NNK. PHITC or PEITC administered in the diet for 22 weeks, a period covering from 1 week before to 1 week after the NNK treatment, exhibited significant inhibition of lung tumorigenesis induced by NNK. The lung tumor incidences in the NNK-treated groups, fed a diet containing 4 mmol/kg (876 ppm) or 2 mmol/kg (438 ppm) PHITC, were 24 and 19% and were 9 and 17% in groups fed PEITC at concentrations of 8 mmol/kg (1304 ppm) or 4 mmol/kg (652 ppm), respectively. In contrast to isothiocyanates, NAC given in the diet at 80 mmol/kg (13056 ppm) or 40 mmol/kg (6528 ppm) exerted no inhibitory effects on the NNK-induced lung tumorigenesis. At the dose studied, NNK did not induce liver and pancreatic tumors in the treated animals, but a significant increase of nasal cavity tumor incidence was observed in the NNK-treated group. However, none of the test compounds showed any effect on the tumorigenesis in this tissue. This study demonstrated that PHITC and PEITC were potent chemopreventive agents for the NNK-induced lung tumorigenesis in F344 rats, whereas NAC was not active at all. These results support further evaluation of these compounds in chemoprevention studies.

1 This work was supported by a Master Agreement Order No. N01-85096-06 from the Division of Cancer Prevention and Control of the National Cancer Institute. This is Paper 22 in the series. "Dietary Inhibitors of Chemical Carcinogenesis."

2 To whom requests for reprints should be addressed, at American Health Foundation, One Dana Road, Valhalla, NY 10595.

Received 9/28/95. Accepted 12/15/95.




This article has been cited by other articles:


Home page
Cancer Prevention ResearchHome page
F. Kassie, I. Matise, M. Negia, D. Lahti, Y. Pan, R. Scherber, P. Upadhyaya, and S. S. Hecht
Combinations of N-Acetyl-S-(N-2-Phenethylthiocarbamoyl)-L-Cysteine and myo-Inositol Inhibit Tobacco Carcinogen-Induced Lung Adenocarcinoma in Mice
Cancer Prevention Research, September 1, 2008; 1(4): 285 - 297.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
C. C. Conaway, C.-X. Wang, B. Pittman, Y.-M. Yang, J. E. Schwartz, D. Tian, E. J. McIntee, S. S. Hecht, and F.-L. Chung
Phenethyl Isothiocyanate and Sulforaphane and their N-Acetylcysteine Conjugates Inhibit Malignant Progression of Lung Adenomas Induced by Tobacco Carcinogens in A/J Mice
Cancer Res., September 15, 2005; 65(18): 8548 - 8557.
[Abstract] [Full Text] [PDF]


Home page
Cancer Epidemiol. Biomarkers Prev.Home page
S. S. Hecht, S. G. Carmella, P. M.J. Kenney, S.-H. Low, K. Arakawa, and M. C. Yu
Effects of Cruciferous Vegetable Consumption on Urinary Metabolites of the Tobacco-Specific Lung Carcinogen 4-(Methylnitrosamino)-1-(3-Pyridyl)-1-Butanone in Singapore Chinese
Cancer Epidemiol. Biomarkers Prev., June 1, 2004; 13(6): 997 - 1004.
[Abstract] [Full Text] [PDF]


Home page
CarcinogenesisHome page
G. Boysen, P. M.J. Kenney, P. Upadhyaya, M. Wang, and S. S. Hecht
Effects of benzyl isothiocyanate and 2-phenethyl isothiocyanate on benzo[a]pyrene and 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone metabolism in F-344 rats
Carcinogenesis, March 1, 2003; 24(3): 517 - 525.
[Abstract] [Full Text] [PDF]


Home page
CarcinogenesisHome page
S. S. Hecht, P. Upadhyaya, M. Wang, R. L. Bliss, E. J. McIntee, and P. M.J. Kenney
Inhibition of lung tumorigenesis in A/J mice by N-acetyl-S-(N-2-phenethylthiocarbamoyl)-L-cysteine and myo-inositol, individually and in combination
Carcinogenesis, September 1, 2002; 23(9): 1455 - 1461.
[Abstract] [Full Text] [PDF]


Home page
CarcinogenesisHome page
D. N. Seril, J. Liao, K.-L. K. Ho, C. S. Yang, and G.-Y. Yang
Inhibition of chronic ulcerative colitis-associated colorectal adenocarcinoma development in a murine model by N-acetylcysteine
Carcinogenesis, June 1, 2002; 23(6): 993 - 1001.
[Abstract] [Full Text] [PDF]


Home page
CarcinogenesisHome page
S. De Flora, A. Izzotti, F. D'Agostini, and R. M. Balansky
Mechanisms of N-acetylcysteine in the prevention of DNA damage and cancer, with special reference to smoking-related end-points
Carcinogenesis, July 1, 2001; 22(7): 999 - 1013.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
A. Izzotti, R. M. Balansky, F. D’Agostini, C. Bennicelli, S. R. Myers, C. J. Grubbs, R. A. Lubet, G. J. Kelloff, and S. De Flora
Modulation of Biomarkers by Chemopreventive Agents in Smoke-exposed Rats
Cancer Res., March 1, 2001; 61(6): 2472 - 2479.
[Abstract] [Full Text]


Home page
CarcinogenesisHome page
F.-L. Chung, C.C. Conaway, C.V. Rao, and B. S. Reddy
Chemoprevention of colonic aberrant crypt foci in Fischer rats by sulforaphane and phenethyl isothiocyanate
Carcinogenesis, December 1, 2000; 21(12): 2287 - 2291.
[Abstract] [Full Text] [PDF]


Home page
Cancer Epidemiol. Biomarkers Prev.Home page
S. S. Hecht, S. G. Carmella, and S. E. Murphy
Effects of Watercress Consumption on Urinary Metabolites of Nicotine in Smokers
Cancer Epidemiol. Biomarkers Prev., October 1, 1999; 8(10): 907 - 913.
[Abstract] [Full Text]


Home page
Cancer Res.Home page
Prevention of Cancer in the Next Millennium: Report of the Chemoprevention Working Group to the American Association for Cancer Research
Cancer Res., October 1, 1999; 59(19): 4743 - 4758.
[Full Text] [PDF]


Home page
J. Nutr.Home page
S. S. Hecht
Chemoprevention of Cancer by Isothiocyanates, Modifiers of Carcinogen Metabolism
J. Nutr., March 1, 1999; 129(3): 768 - 768.
[Abstract] [Full Text]


Home page
JNCI J Natl Cancer InstHome page
S. D. Hursting, T. J. Slaga, S. M. Fischer, J. DiGiovanni, and J. M. Phang
Mechanism-Based Cancer Prevention Approaches: Targets, Examples, and the Use of Transgenic Mice
J Natl Cancer Inst, February 3, 1999; 91(3): 215 - 225.
[Abstract] [Full Text] [PDF]


Home page
Drug Metab. Dispos.Home page
C. C. Conaway, D. Jiao, T. Kohri, L. Liebes, and F.-L. Chung
Disposition and Pharmacokinetics of Phenethyl Isothiocyanate and 6-Phenylhexyl Isothiocyanate in F344 Rats
Drug Metab. Dispos., January 1, 1999; 27(1): 13 - 20.
[Abstract] [Full Text]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 1996 by the American Association for Cancer Research.